CSF2 and schistosomiasis: The likelihood of integrating GM-CSF assessment into routine diagnostic and monitoring protocols unprecedentedly constitutes a prospect of ameliorated diagnostic (Figure 7), enhanced risk stratification, optimized treatment strategies, and improved patient outcomes in schistosomiasis endemic regions.